Stock Analysis
XP Inc. (XP) Stock Analysis
XP Inc. (XP) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
XP Inc. (XP) currently has an AIQ Score of 59/100, indicating a neutral setup. Momentum is the strongest factor at 79/100. Risk is the weakest current factor at 43/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
XP at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $19.86 |
| AIQ Score | 59/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Strong Buy |
| Market Cap | $9.79B |
| P/E Ratio | 9.8 |
| Forward P/E | — |
| EPS | $2.79 |
| Revenue TTM | $4.99B |
| Dividend Yield | 0.01% |
| Beta | 1.1 |
| Volume | 8.04M |
| 52-week range | $14.80-$23.13 |
| RSI 14 | 76.52 |
| 50-Day SMA | $17.13 |
| 200-Day SMA | $18.07 |
| Analyst Price Target | $22.00 |
| Next Earnings | Nov 16, 2026 |
XP
OverviewXP Stock Analysis Summary
XP Inc. (XP) currently has an AIQ Score of 59/100, indicating a neutral setup. Momentum is the strongest factor at 79/100. Risk resilience is the weakest current factor at 43/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, XP has AIQ Score of 59/100 with Momentum base of 79/100 and fading Risk resilience at 43/100. Wait for component alignment before adding exposure.
Momentum (79/100) leads while Risk resilience (43/100) lags. This cross-factor spread creates entry timing uncertainty.
Financial Services · -0.55% stock move · XP classified in Financial - Capital Markets.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is XP Bullish or Bearish Right Now?
XP currently has a neutral overall setup. Momentum is the strongest factor at 79/100, while Risk Resilience is weakest at 43/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Momentum is constructive at 79/100.
- - Price is +15.92% above its 50-day SMA.
- - Analyst target implies +10.78% upside from the latest quote.
- - Technical consensus has more buy votes than sell votes (36 vs 3).
- - Risk Resilience is weak at 43/100.
Current Consensus
XP's Technical Analysis Consensus is currently Strong Buy, with 36 buy, 6 neutral, and 3 sell votes. XP's 14-day RSI is 76.52, which places the stock in an overbought momentum range. XP's beta is 1.1, indicating market sensitivity broadly in line with the market.
What Changed in XP?
Recent score-change history is not available in the current snapshot. These are the latest market-close scores instead.
What Would Change the XP Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
XP Decision Framework
Public evidence layers, setup checks, and risk context for XP Inc..
XP Inc. (XP) Stock Analysis
XP Inc. has an AIQ Score of 59/100 in a Neutral regime. Momentum is strongest at 79/100. Beta is 1.1, close to market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | XP is in a Neutral AIQ regime with score 59/100. |
| Signal Conflict | The primary conflict is that momentum leads at 79/100 while risk lags at 43/100. |
| Factor Evidence | Momentum 79/100 · Value 57/100 · Quality 52/100 · Risk 43/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Momentum is the strongest factor at 79/100.
Momentum is 79/100 and RSI (14) is 76.5.
XP is in a Neutral regime at 59/100.
Risk factor is 43/100 with beta 1.1 and annual volatility 46.48%.
Current conflict: momentum leads at 79/100 while risk lags at 43/100.
XP Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
XP Fundamentals
XP valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
XP Technical Analysis
XP technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
XP Stock Catalysts
Track XP earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
XP Dividend Analysis
XP dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
XP Financial Data
XP revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
XP Risk Analysis
XP volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
XP Stock News
XP stock news, market tone, recent headlines, and catalyst context.
XP vs Fintech & Payments Peers
Current peer cohort: XP · AFRM · CPAY · DAVE · ENVA. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| XP Current stock | 59/100 | 57/100 | 79/100 | 43/100 | 0.28 | 46.48% | Current |
| AFRM Affirm | 48/100 | 42/100 | 37/100 | 28/100 | -0.05 | 60.08% | XP vs AFRM |
| CPAY Corpay | 58/100 | 65/100 | 48/100 | 60/100 | 0.87 | 37.07% | XP vs CPAY |
| DAVE Dave Inc | 57/100 | 52/100 | 48/100 | 31/100 | 1 | 70.05% | XP vs DAVE |
| ENVA Enova International | 48/100 | 52/100 | 30/100 | 53/100 | 1.74 | 40.62% | XP vs ENVA |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Sep 11, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts7 recent quarterly periods are available for review.
Checked Sep 12, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching XP
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for XP
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
XP Stock FAQ
What is XP stock price today?
XP Inc.'s current stock price is $19.86. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is XP bullish or bearish right now?
XP's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is XP's market cap?
XP's market cap is $9.79B based on the latest completed market-close snapshot from Sep 11, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is XP's current P/E ratio?
XP's current P/E ratio is 9.8 based on the latest completed market-close snapshot from Sep 11, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is XP's RSI?
XP's 14-day RSI is 76.52 based on the latest completed market-close snapshot from Sep 11, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is XP above its 50-day and 200-day moving averages?
XP is 15.92% from its 50-day SMA and 9.89% from its 200-day SMA based on the latest completed market-close snapshot from Sep 11, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is XP's next earnings date?
XP's next earnings date is currently listed as Nov 16, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does XP pay a dividend?
XP's dividend yield is 0.01% based on the latest completed market-close snapshot from Sep 11, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.